340B Drug Pricing Program
The Health Resources and Services Administration today delayed to May 22 the effective date of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers, and invited comments on whether a delay to Oct. 1 would be more appropriate.
鈥淐ongress should preserve the 340B Drug Pricing Program and protect patients and communities,鈥 writes AHA Executive Vice President Tom Nickels in an AHA Stat blog post. He notes, 鈥淓very day, we see stories about the exorbitant costs of prescription drugs and the serious challenges they pose for鈥
Every day, we see stories about the exorbitant costs of prescription drugs and the serious challenges they pose for individuals and the entire health care system.
One program that has a 25-year track record of improving access to medications and health care services for people in vulnerable鈥
The Health Resources and Services Administration today delayed, in accordance with a recent White House memorandum, the effective date of its final rule on drug ceiling prices and civil monetary penalties for
The administration yesterday withdrew the Health Resources and Services Administration鈥檚 pending omnibus guidance for the 340B Drug Pricing Program. 鈥淲e are pleased that the Administration chose not to finalize the Health Resources and Services Administration鈥檚 guidance, which, if enacted鈥
The Health Resources and Services Administration today released a final rule on drug ceiling prices and civil monetary penalties for manufacturers in the 340B Drug Pricing Program.
The Health Resources and Services Administration鈥檚 proposed rule that would establish an administrative dispute resolution process for the 340B Drug Pricing Program 鈥渋s an important first step for 340B hospitals and clinics that have been overcharged for drugs purchased through the program,鈥 but鈥
New analysis finds inpatient hospital drug costs increased more than 38% per admission between 2013 and 2015.
Tomorrow is the last day that hospitals can recertify for the 340B Drug Pricing Program. All 340B hospitals are required to recertify annually with the Health Resources and Services Administration to ensure they continue to meet 340B hospital eligibility requirements. To access a recent HRSA鈥